NFKB1 and neoplasm: Interestingly, dimethyl fumarate (DMF) was recently shown to enhance OV infection of cancer cells and improve therapeutic outcomes in resistant syngeneic and xenograft tumour mouse models through inhibition of NF-κB signalling and, in turn, the antiviral response of cancer cells [212].